» Articles » PMID: 23263494

Death-related Factors of Systemic Lupus Erythematosus Patients Associated with the Course of Disease in Chinese Populations: Multicenter and Retrospective Study of 1,958 Inpatients

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2012 Dec 25
PMID 23263494
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the improved survival rate among systemic lupus erythematosus (SLE) patients, there are many factors associated with the mortality of SLE. In the current study, death-related factors of patients associated with course of disease were surveyed. Retrospective study was used. Mortalities among these three groups (group A, B and C, the course of disease was ≤ 5 years, 5-10 years and > 10 years, respectively) were calculated and compared. Various factors related to mortality were analyzed. Male SLE patients died relatively more than female patients. The total mortality was 8.5 %. The mortalities were significant difference in group A, B and C which were 9.4, 4.8 and 8.9 %, respectively. The mortalities of group A and group C were significantly higher than that of group B, but there was no significant difference between mortalities of group A and group C. The most common death-related factor was infection, followed by involved disorders in renal, brain, multisystem, heart, etc. The mortalities resulted from neuropsychiatric systemic lupus erythematosus (NPSLE), pulmonary infection, involved digestive system and hematological system were significantly different between three groups. There was no difference between mortalities of group A and group C associated with pulmonary infection and NPSLE. Patients in group C died more than in group A from involved renal, heart, multisystem, etc, while group A had more patients than group C who died of pulmonary infection, involved hematological system. In conclusion, Male SLE patients have worse outcome than female patients. Infection and active SLE are not only contributors to the death of early stage patients, but also to that of later stage patients.

Citing Articles

Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry.

Moreno-Torres V, Tarin C, Ruiz-Irastorza G, Castejon R, Gutierrez-Rojas A, Royuela A J Clin Med. 2021; 10(24).

PMID: 34945045 PMC: 8707218. DOI: 10.3390/jcm10245749.


Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects.

Yao X, Wu Y, Jiang J, Hu P, Liu D, Chen X Clin Drug Investig. 2019; 39(7):643-651.

PMID: 31016613 DOI: 10.1007/s40261-019-00786-5.


Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period.

Padjen I, Cerovec M, Erceg M, Mayer M, Stevanovic R, Anic B Croat Med J. 2018; 59(1):3-12.

PMID: 29498492 PMC: 5833101. DOI: 10.3325/cmj.2018.59.3.


Significant Reductions in Mortality in Hospitalized Patients with Systemic Lupus Erythematosus in Washington State from 2003 to 2011.

Goss L, Ortiz J, Okamura D, Hayward K, Goss C PLoS One. 2015; 10(6):e0128920.

PMID: 26087254 PMC: 4473009. DOI: 10.1371/journal.pone.0128920.

References
1.
Abu-Shakra M, Gladman D, Urowitz M . Mortality studies in SLE: how far can we improve survival of patients with SLE. Autoimmun Rev. 2004; 3(6):418-20. DOI: 10.1016/j.autrev.2004.07.003. View

2.
Alamanos Y, Voulgari P, Papassava M, Tsamandouraki K, Drosos A, Parassava M . Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology (Oxford). 2003; 42(9):1122-3. DOI: 10.1093/rheumatology/keg291. View

3.
Abu-Shakra M, Urowitz M, Gladman D, Gough J . Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol. 1995; 22(7):1259-64. View

4.
Fessler B . Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol. 2002; 16(2):281-91. DOI: 10.1053/berh.2001.0226. View

5.
Rabbani M, Habib H, Islam M, Ahmad B, Majid S, Saeed W . Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients. Lupus. 2009; 18(9):848-55. DOI: 10.1177/0961203309103410. View